H11 Stock Chart & Stats
€41.48
€2.78(6.92%)
At close: 4:00 PM EDT
€41.48
€2.78(6.92%)
Day’s Range― - ―
52-Week Range€37.36 - €56.60
Previous CloseN/A
Volume40.00
Average Volume (3M)435.00
Market Cap
€15.83B
Enterprise Value€15.20B
Total Cash (Recent Filing)€143.40M
Total Debt (Recent Filing)€913.40M
Price to Earnings (P/E)35.4
Beta0.71
Next Earnings
Nov 19, 2026EPS Estimate
0.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.98
Shares Outstanding379,645,360
10 Day Avg. Volume353
30 Day Avg. Volume435
Financial Highlights & Ratios
PEG Ratio1.52
Price to Book (P/B)6.62
Price to Sales (P/S)5.56
P/FCF Ratio36.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€52.35Price Target Upside26.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.02
Revenue Forecast (FY)€35.09M
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthConsistent multi-year revenue growth, including a clear step-up in the latest annual period, indicates sustained demand across Halma’s safety, healthcare, and environmental activities. This supports operating scale, strengthens the platform for future investment, and reduces dependence on a single reporting period.
Strong ProfitabilityHigh-teens to low-20% operating margins and a healthy mid-teens net margin show that Halma converts its specialized products into substantial profit. Durable profitability can fund research, acquisitions, and market expansion while providing resilience across its diversified end markets.
Healthy Free Cash FlowMaterial free-cash-flow growth and high-80% conversion from net income demonstrate strong underlying cash generation. This gives Halma capacity to reinvest in its technology portfolio, support shareholder returns, and manage obligations without relying exclusively on external financing.
Bears Say
Rising Total DebtAlthough leverage remains moderate, the upward trend in total debt could gradually reduce financial flexibility if profitability or cash conversion weakens. Higher absolute obligations may constrain acquisition, investment, or shareholder-return capacity and increase sensitivity to future funding conditions.
Volatile Operating Cash FlowOperating cash flow that varies more than earnings, and falls below operating profit in some periods, points to working-capital or timing swings. If persistent, this could make internally generated funding less predictable and weaken confidence that accounting profits consistently translate into usable cash.
Reported Zero Gross ProfitA reported zero gross profit and gross margin for the latest year prevents a dependable assessment of the current cost structure and gross-profit trend. Until the figure is clarified, uncertainty remains around the durability of product-level economics beneath the otherwise strong operating and net margins.
Halma plc News
H11 FAQ
What was Halma PLC’s price range in the past 12 months?
Halma PLC lowest stock price was €37.36 and its highest was €56.60 in the past 12 months.
What is Halma PLC’s market cap?
Halma PLC’s market cap is €15.83B.
When is Halma PLC’s upcoming earnings report date?
Halma PLC’s upcoming earnings report date is Nov 19, 2026 which is in 36 days.
How were Halma PLC’s earnings last quarter?
Halma PLC released its earnings results on Jun 11, 2026. The company reported €0.695 earnings per share for the quarter, beating the consensus estimate of €0.677 by €0.018.
Is Halma PLC overvalued?
According to Wall Street analysts Halma PLC’s price is currently Undervalued.
Does Halma PLC pay dividends?
Halma PLC does not currently pay dividends.
What is Halma PLC’s EPS estimate?
Halma PLC’s EPS estimate is 0.74.
How many shares outstanding does Halma PLC have?
Halma PLC has 379,645,360 shares outstanding.
What happened to Halma PLC’s price movement after its last earnings report?
Halma PLC reported an EPS of €0.695 in its last earnings report, beating expectations of €0.677. Following the earnings report the stock price went down -16.082%.
Which hedge fund is a major shareholder of Halma PLC?
Currently, no hedge funds are holding shares in DE:H11
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Halma plc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€52.35 (26.22% Upside)
€52.35 (26.22% Upside)
Blogger Sentiment
Bullish
DE:H11 Sentiment 100%
Sector Average 64%
Sector Average 64%
Insider Transactions
Sold Shares
Worth €3.0M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.58%
12-Months-Change
Fundamentals
Return on Equity
17.92%
Trailing 12-Months
Asset Growth
13.94%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Halma PLC
Halma plc, a company established in 1894 and headquartered in Amersham, United Kingdom, specializes in delivering innovative technological solutions across critical safety, health, and environmental sectors. Its operations are organized into three distinct divisions: Safety, Environmental & Analysis, and Medical. The Safety division offers a range of protective technologies, encompassing fire detection and advanced suppression systems, safety mechanisms for elevators, security sensors, and systems for managing pedestrian and vehicle movement. It also develops specialized interlocks for secure process control, as well as solutions for explosion prevention and corrosion oversight. These offerings cater to various applications, including elevator safety, fire management, crowd and traffic flow, industrial access, and secure storage solutions. Focused on monitoring and analysis, the Environmental & Analysis segment provides advanced optical, optoelectronic, and spectral imaging solutions. It also develops instruments for tracking water, air, and gas quality, including devices to detect hazardous gases and assess overall air purity, alongside comprehensive water analysis and treatment systems. Its expertise serves fields such as optical diagnostics, water management, gas detection, and broad environmental monitoring. The Medical division is dedicated to healthcare innovations, supplying essential fluidic components for medical diagnostics and original equipment manufacturers. It also produces laboratory instruments and platforms designed to provide crucial insights into patient health, aiding providers in clinical decision-making. Furthermore, the segment develops specialized technologies and approaches to facilitate in-vitro diagnostics, scientific discoveries, and product development in life sciences, ensuring beneficial outcomes across diverse medical specialties.
H11 Stock 12 Month Forecast
Average Price Target
€52.35
▲(26.22% Upside)